Sunshine Biopharma (SBFM) EPS (Basic) Growth (3y) (2021 - 2026)
Sunshine Biopharma (SBFM) EPS (Basic) Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 50.53% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 6.20% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -70.04% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 6.69% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -6.51% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 65.05% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -18.26% |
| 10 | Sunshine Biopharma | 750,608.81 | -6.16 Mn | 2.18 Mn | 88.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 88.20% |
| Dec 31, 2025 | 94.50% |
| Sep 30, 2025 | 26.00% |
| Jun 30, 2025 | 78.71% |
| Mar 31, 2025 | 90.23% |
| Dec 31, 2024 | -26.12% |
| Sep 30, 2024 | 93.33% |
| Jun 30, 2024 | 75.39% |
| Mar 31, 2024 | 80.76% |
| Dec 31, 2022 | -29.27% |
| Jun 30, 2022 | -35.43% |
| Mar 31, 2022 | -30.40% |
| Dec 31, 2021 | 34.32% |
| Sep 30, 2021 | -100.22% |
| Jun 30, 2021 | -85.98% |
| Mar 31, 2021 | 38.54% |